Details for New Drug Application (NDA): 020844
✉ Email this page to a colleague
The generic ingredient in TOPAMAX SPRINKLE is topiramate. There are twenty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the topiramate profile page.
Summary for 020844
Tradename: | TOPAMAX SPRINKLE |
Applicant: | Janssen Pharms |
Ingredient: | topiramate |
Patents: | 0 |
Pharmacology for NDA: 020844
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Cytochrome P450 3A4 Inducers |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 020844
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOPAMAX | topiramate | CAPSULE;ORAL | 020844 | NDA | Janssen Pharmaceuticals, Inc. | 50458-645 | 50458-645-65 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (50458-645-65) |
TOPAMAX SPRINKLE | topiramate | CAPSULE;ORAL | 020844 | NDA | Janssen Pharmaceuticals, Inc. | 50458-645 | 50458-645-65 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (50458-645-65) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 15MG | ||||
Approval Date: | Oct 26, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 26, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 26, 1998 | TE: | RLD: | Yes |
Expired US Patents for NDA 020844
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | TOPAMAX SPRINKLE | topiramate | CAPSULE;ORAL | 020844-003 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX SPRINKLE | topiramate | CAPSULE;ORAL | 020844-003 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX | topiramate | CAPSULE;ORAL | 020844-002 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX | topiramate | CAPSULE;ORAL | 020844-001 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX | topiramate | CAPSULE;ORAL | 020844-001 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX | topiramate | CAPSULE;ORAL | 020844-001 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | TOPAMAX | topiramate | CAPSULE;ORAL | 020844-002 | Oct 26, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription